Provided by Tiger Trade Technology Pte. Ltd.

Arcutis Biotherapeutics Inc.

26.30
+1.817.39%
Volume:1.19M
Turnover:30.97M
Market Cap:3.29B
PE:122.09
High:26.97
Open:24.50
Low:24.30
Close:24.49
52wk High:31.77
52wk Low:19.30
Shares:125.07M
Float Shares:111.18M
Volume Ratio:0.59
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2154
EPS(LYR):-0.1269
ROE:15.86%
ROA:5.09%
PB:14.91
PE(LYR):-207.32

Loading ...

Jan 11, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 31, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 24, 2023

Major Issues Report

Form 8-K - Current report
Oct 19, 2023

Major Issues Report

Form 8-K - Current report
Sep 27, 2023

Major Issues Report

Form 8-K - Current report
Sep 16, 2023

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Sep 16, 2023

Correspondence

Form CORRESP - Correspondence
Sep 15, 2023

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Sep 15, 2023

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Sep 07, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]